With 29.21M Outstanding Shares, Can Candel Therapeutics Inc (NASDAQ: CADL) Deliver Big Short-Term Gains?

Candel Therapeutics Inc (NASDAQ:CADL) currently has a daily average trading volume of 5.53M but it saw 1679303 shares traded in last market. With a market cap of 410.90M USD, the company’s current market price of $14.00 came rising about 30.84 while comparing to the previous closing price of $10.70. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.40 and as low as $0.66.

Taking a look at 20-day trading activity of Candel Therapeutics Inc (CADL) gives us an average price of $8.16, while its current price level is 22.81% below from 52-week high level whereas it is 2021.21% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $5.11 while that of 200 days or SMA-200 reads an average of $2.15. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.49% during that period while stretching the period over a month that decreases to 14.43%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 81.13 which implies that the stock is in overbought territory.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on December 02, 2022, recommending a price target of $11 for it. UBS also issued its recommendations for the stock as it initiated the price target for the stock is $9.

Over the week, CADL’s stock price is moving 29.27% up while it is 137.69% when we observe its performance for the past one month. Year-to-date it is 852.38% up and over the past year, the stock is showing an upside performance of 775.00%.

Currently, Candel Therapeutics Inc’s total number of outstanding shares is 29.21M. Company’s return on investment (ROI) stands at -222.80% and return on equity (ROE) at -163.77%. Stock’s beta reads -0.75. Stock has a price to book (P/B) ratio of 68.72. Its return on asset (ROA) is -75.90% on average.